TMCI
Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. insider trading
Insiders at Treace Medical Concepts, Inc. have been buying its stock on the open market. The largest purchase in the last 30 days was Treace John T. (Chief Executive Officer · Director) buying $177.2K of TMCI, filed Aug 24, 2026. Every open-market purchase and sale its officers, directors and 10% owners filed in that time is listed below, each linked to the original Form 4.
- Bought on the open market
- $246.7K
- Sold
- —
- Insiders
- 1
- Latest trade
- Aug 20, 2026
From SEC filings · last 30 days
Recent TMCI insider transactions
Treace John T.Chief Executive Officer · Director
Bought 39,944 sh at $4.44 · Aug 20, 2026
$177.2K
FilingTreace John T.Chief Executive Officer · Director
Bought 11,000 sh at $4.34 · Aug 24, 2026
$47.7K
FilingTreace John T.Chief Executive Officer · Director
Bought 5,000 sh at $4.35 · Aug 21, 2026
$21.7K
Filing
SEC Form 4 data, Q3 2024 to Q2 2026
TMCI insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 3 insiders traded TMCI on the open market: 15 purchases worth $3M and 1 sale worth $398.5K, the sale pre-scheduled under a 10b5-1 plan. In the last four quarters alone: 11 purchases ($1.2M) and 0 sales, by one insider.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | +$1.2M11 buys | — | |
| Q1 2026 | — | — | |
| Q4 2025 | — | — | |
| Q3 2025 | — | — | |
| Q2 2025 | — | — | |
| Q1 2025 | +$523.8K1 buy | −$398.5K1 sale · all on a plan | |
| Q4 2024 | — | — | |
| Q3 2024 | +$1.3M3 buys | — |
- Largest purchase
- +$523.8K of TMCI by Treace John T. (Chief Executive Officer · Director) on Mar 04, 2025.
- Largest sale
- −$398.5K of TMCI by Scanlan Sean F. (Chief Innovation Officer) on Mar 17, 2025, under a 10b5-1 plan.
Open-market transactions through Jun 30, 2026most recent first
Treace John T.
Chief Executive Officer · Director
+$92.5K
Jun 11, 2026
22,887 sh · $4.04
Treace John T.
Chief Executive Officer · Director
+$40K
Jun 11, 2026
9,891 sh · $4.04
Treace John T.
Chief Executive Officer · Director
+$118.3K
Jun 10, 2026
29,430 sh · $4.02
Treace John T.
Chief Executive Officer · Director
+$59.2K
Jun 10, 2026
14,715 sh · $4.02
Treace John T.
Chief Executive Officer · Director
+$178K
Jun 01, 2026
50,000 sh · $3.56
Treace John T.
Chief Executive Officer · Director
+$184.8K
May 28, 2026
61,202 sh · $3.02
Treace John T.
Chief Executive Officer · Director
+$143K
May 27, 2026
49,810 sh · $2.87
Treace John T.
Chief Executive Officer · Director
+$12.6K
May 26, 2026
4,508 sh · $2.79
Treace John T.
Chief Executive Officer · Director
+$161.8K
May 14, 2026
61,750 sh · $2.62
Treace John T.
Chief Executive Officer · Director
+$120.6K
May 13, 2026
49,013 sh · $2.46
Treace John T.
Chief Executive Officer · Director
+$93.3K
May 12, 2026
43,000 sh · $2.17
Scanlan Sean F.10b5-1
Chief Innovation Officer
−$398.5K
Mar 17, 2025
50,000 sh · $7.97
Treace John T.
Chief Executive Officer · Director
+$523.8K
Mar 04, 2025
60,000 sh · $8.73
Treace John T.
Chief Executive Officer · Director
+$265.5K
Sep 16, 2024
50,000 sh · $5.31
Treace James T
Director
+$500.6K
Aug 15, 2024
84,000 sh · $5.96
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Jun 11, 2026 | Treace John T.Chief Executive Officer · Director | 22,887 | $4.04 | +$92.5K |
| Jun 11, 2026 | Treace John T.Chief Executive Officer · Director | 9,891 | $4.04 | +$40K |
| Jun 10, 2026 | Treace John T.Chief Executive Officer · Director | 29,430 | $4.02 | +$118.3K |
| Jun 10, 2026 | Treace John T.Chief Executive Officer · Director | 14,715 | $4.02 | +$59.2K |
| Jun 01, 2026 | Treace John T.Chief Executive Officer · Director | 50,000 | $3.56 | +$178K |
| May 28, 2026 | Treace John T.Chief Executive Officer · Director | 61,202 | $3.02 | +$184.8K |
| May 27, 2026 | Treace John T.Chief Executive Officer · Director | 49,810 | $2.87 | +$143K |
| May 26, 2026 | Treace John T.Chief Executive Officer · Director | 4,508 | $2.79 | +$12.6K |
| May 14, 2026 | Treace John T.Chief Executive Officer · Director | 61,750 | $2.62 | +$161.8K |
| May 13, 2026 | Treace John T.Chief Executive Officer · Director | 49,013 | $2.46 | +$120.6K |
| May 12, 2026 | Treace John T.Chief Executive Officer · Director | 43,000 | $2.17 | +$93.3K |
| Mar 17, 2025 | Scanlan Sean F.10b5-1Chief Innovation Officer | 50,000 | $7.97 | −$398.5K |
| Mar 04, 2025 | Treace John T.Chief Executive Officer · Director | 60,000 | $8.73 | +$523.8K |
| Sep 16, 2024 | Treace John T.Chief Executive Officer · Director | 50,000 | $5.31 | +$265.5K |
| Aug 15, 2024 | Treace James TDirector | 84,000 | $5.96 | +$500.6K |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Don't check TMCI — let it ping you
Watch every insider filing the minute it clears the SEC
The live dashboard reads every Form 4 as it lands and puts it in plain English — open-market buys, cluster buys where several insiders move at once, and the sales executives chose to make rather than scheduled. Free to open; Pro adds alerts, watchlists and each buyer's track record.
Treace Medical Concepts, Inc. is outside the ~660 companies InsiderPulse scans continuously. This page is built from the filings on the live tape and stays up while its insiders are buying. Monitoring, not advice.
Other companies insiders are buying now
Questions
- Are TMCI insiders buying or selling?
- Between Aug 21, 2026 and Aug 20, 2026, 1 Treace Medical Concepts, Inc. insider made 3 open-market purchases worth $246.7K and no sales, a net purchase of $246.7K.
- How much TMCI stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 3 Treace Medical Concepts, Inc. insiders made 15 open-market purchases worth $3M and 1 sale worth $398.5K. Every one of the sales was pre-scheduled under a Rule 10b5-1 plan. In the four quarters to Jun 30, 2026: 11 purchases ($1.2M) and no sales. The largest purchase was Treace John T. buying $523.8K on Mar 04, 2025. The largest sale was Scanlan Sean F. selling $398.5K on Mar 17, 2025.
- What was the largest recent TMCI insider trade?
- Treace John T. (Chief Executive Officer · Director) bought $177.2K of TMCI stock on Aug 20, 2026 at about $4.44 a share.
- When did an insider last buy TMCI shares?
- The most recent open-market purchase on file is Treace John T. (Chief Executive Officer · Director) buying $47.7K on Aug 24, 2026. The largest purchase in the period was $177.2K by Treace John T..
- Where does TMCI insider trading data come from?
- From the Form 4 filings Treace Medical Concepts, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
The week's real signals — open-market insider buys, cluster formations and what insiders did in TMCI and across the market — in plain English, with grants and routine vesting stripped out. Free, and honest about what the data can and cannot say.